Cite

HARVARD Citation

    Sampson, J. et al. (2021). CTIM-28. MDNA55, AN INTERLEUKIN-4 RECEPTOR TARGETED IMMUNOTHERAPY, FOR RECURRENT GBM DELIVERED BY CONVECTION ENHANCED DELIVERY (CED). Neuro-oncology. pp. vi56-vi57. [Online]. 
  
Back to record